USPTO serial 88983784
CYTIVA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 12, 2022
- Examiner
- LAW, CHRISTOPHER M
- Law office
- TMEG LAW OFFICE 103
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CYTIVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Life Sciences IP Holdings Corporation
Washington, DC
Other trademarks owned by Life Sciences IP Holdings Corporation
Life Sciences IP Holdings Corporation
Washington, DC
Other trademarks owned by Life Sciences IP Holdings Corporation
Life Sciences IP Holdings Corporation
Washington, DC
Other trademarks owned by Life Sciences IP Holdings Corporation
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dyan House
Dyan House Baker & McKenzie LLP1900 N. Pearl Street, Suite 1500Dallas, TX 75201United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Consulting in the field of contract manufacturing in life sciences and bioprocessing | ACTIVE | Apr 1, 2020 |
| 041 | Customer training and educational courses in the fields of chemicals, life science, pharmaceuticals, biotherapeutics, cell and gene therapy production; education services, namely, conducting classes, seminars, and virtual workshops in the field of automation of biomanufacturing processes; training relating to the automation of biomanufacturing processes; education services, namely, conducting classes, seminars, and virtual workshops in the field of biomanufacturing; education services, namely, conducting classes, seminars, and virtual workshops relating to biomanufacturing, bioprocessing, cell and gene therapy, and production-scale manufacturing of biopharmaceuticals, engineering; education services, namely, providing training courses, seminars and instructional classes in the field(s) of life sciences and bioprocessing; training and educational courses in relation to scientific apparatus, scientific instruments, and life science software; training relating to the use, calibration, re-calibration and servicing of scientific apparatus and instruments; education services related to cell and gene therapy implemented with cryochain technology, biomanufacturing and bioprocessing, and production-scale manufacturing of biopharmaceuticals, in the form of classes, seminars, and courses of instruction | ACTIVE | Apr 1, 2020 |
| 042 | Research, advising, and consulting related to life sciences, laboratory support services being medical and scientific laboratory services, laboratory testing, laboratory analysis, development of pharmaceutical products, environmental testing, virology, bacteriology, bioprocess science, medical and scientific research concerning cell and gene therapy, development of vaccine products, food and beverage testing; software as a service, namely, software for analyzing and processing large sets of data; scientific research and consulting in the field of building construction and construction of customized, pre-fabricated, and deliverable research and production facilities; product research and development in life sciences and bioprocessing; development of cloud based computer programs for simulating laboratory testing; providing on-line non-downloadable computer modeling software for biopharma process development; software as a service (SAAS) services, platform as a service (PAAS), and cloud based services featuring software for customization, optimization, utilization, modeling, and emulation relating to bioprocessing and bioprocess development; software as a service (SAAS) services featuring manufacturing execution system (MES) software for the pharmaceutical and biotechnology industries; design of bioprocessing facility buildings and rooms therein for the life sciences industry; bioprocess engineering; process development services; scientific consultancy and advising in the fields of bioprocess production methods and production lines; design and development of bioprocess products and production line products; providing an online portal featuring information in the life sciences field; providing temporary use of non-downloadable software, namely, software for optimization, obtaining performance data, maintenance, remote diagnostics and troubleshooting, connectivity, calibration qualification, processing trade-ins, and providing information about spare parts and kits, all for life science and bioprocess equipment ; technical support services, namely, troubleshooting of computer hardware and software problems; testing, analysis and evaluation of the goods of others to determine conformity with certification standards; rental and donation of laboratory apparatus and instruments; platform as a service (PAAS) services featuring educational computer software platforms for providing online learning and virtual classrooms in the fields of life sciences, laboratory support, laboratory testing, laboratory analysis, pharmaceutical production, environmental testing, virology, bacteriology, bioprocess, cell and gene therapy, vaccine production, food and beverage testing; designing biomanufacturing process lines for the life sciences industry; shared information technology infrastructure services for the production of biopharmaceuticals | ACTIVE | Apr 1, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Life Sciences IP Holdings Corporation
- Other trademarks owned by Life Sciences IP Holdings Corporation
- Other trademarks owned by Life Sciences IP Holdings Corporation
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named CYTIVA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 5, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 5, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 5, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 17, 2023 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Dec 13, 2022 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Dec 7, 2022 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Dec 6, 2022 | PRAM | POST REGISTRATION ACTION MAILED - SEC. 7 | — |
| Dec 6, 2022 | XXXX | POST REGISTRATION ACTION CORRECTION | — |
| Dec 6, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 30, 2022 | WDRL | OTQR WITHDRAWAL FROM PUBLICATION | — |
| Oct 18, 2022 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Oct 12, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 16, 2022 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Apr 12, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 9, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 8, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Feb 8, 2022 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Feb 7, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 7, 2022 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Feb 4, 2022 | IROA | RESPONSE TO ITU OFFICE ACTION ENTERED | — |
| Feb 4, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 3, 2022 | INCD | ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST | — |
| Feb 3, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 24, 2022 | IUAF | USE AMENDMENT FILED | — |
| Jan 24, 2022 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jan 24, 2022 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jan 24, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 6, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 4, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 4, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 4, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 6, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 20, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 5, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 5, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 5, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 4, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 4, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 4, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 4, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 26, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 25, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 25, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 28, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 28, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 28, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 15, 2020 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 14, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 5, 2020 | NWAP | NEW APPLICATION ENTERED | — |